Timid Replacement Secretary Discovers the Tools for a Powerf - hormone replacement therapy and fibrocystic breast


hormone replacement therapy and fibrocystic breast - Timid Replacement Secretary Discovers the Tools for a Powerf

There is no history of breast cancer in our family, but she is plagued with fibrocystic breast disease. She’s worried that her fibrous cysts will make it difficult to identify a cancerous tumor should one appear. What are your thoughts on fibrocystic breast disease, hormone replacement therapy (HRT) and breast . In that study, a higher rate of fibrocystic breast disease was found in users of estrogen replacement therapy than in nonusers. The researcher concluded that it could not be determined from these data whether the higher rate of disease was the result of higher hormone use or of the higher detection rate of breast disease in women who were taking hormone therapy and having their breasts examined .

Fibrocystic breast disease dissipates completely after natural menopause, when breast size decreases. However, if the woman takes a higher dose estrogen replacement therapy, fibrocystic breast disease can worsen. Aspiration of the breast with a fine needle can often diagnose and treat larger cysts. Next page: Further Information about Fibrocystic Breast Disease. Use of estrogen replacement therapy was positively associated with fibrocystic breast disease; the odds of disease increased with duration of use, reaching an approximately fivefold excess odds for those who had taken menopausal estrogens for 10 or more bihada-josei.info by:

It has been recommended that hormone replacement is withheld from women with increased risk of breast cancer based on personal or family history, lifestyle, increased breast density or fibrocystic breast disease, and that hormone replacement should be . Hormone replacement (HRT) worsens fibrocystic breast conditions, especially if the HRT includes a progestin. It is interesting that some HRT is worse than others depending upon which progestin is used; cyproterone acetate and medroxyprogesterone acetate seem to produce higher incidences of fibrocystic change on x-ray (1).